Table 2. Characteristics of include studies.
| Authors/Year | Year | Study period | Age mean (range) | Cases | Type | Markers | Methods | TAM distribution | NOS score | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stroma | High expression | Counts | |||||||||
| Chen, X.J. et al. [15] | 2019 | 2011–2013 | NR | 38 | SCC | CD163 | IHC | ✓ | _ | _ | 7 |
| Chen, et al. [16] | 2019 | 2012.1–2013.12 | NR | 72 | NR | CD163 | IHC | ✓ | ✓ | _ | 6 |
| Yan, et al. [17] | 2018 | 2011.1–2013.12 | NR | 41 | SCC | CD163 | IHC | ✓ | ✓ | ✓ | 7 |
| Liu, et al. [18] | 2018 | 2013.6–2016.6 | 50 (35–82) | 65 | SCC | CD68 | IHC | ✓ | ✓ | _ | 7 |
| Wang, et al. [19] | 2018 | 2014.12–2017.6 | NR (24–81) | 100 | SCC, AC and ASC | CD68, CD163 | IHC | _ | ✓ | _ | 6 |
| Li, et al. [20] | 2017 | 2012.1–2012.12 | NR | 109 | SCC | CD163 | IHC | ✓ | _ | ✓ | 6 |
| Chen, et al. [21] | 2017 | 2011–2013 | NR | 45 | SCC | CD68, CD163 | IHC | ✓ | ✓ | ✓ | 7 |
| Shen, et al. [22] | 2016 | 2013–2015 | NR (28–71) | 60 | SCC,AC, ASC and NC | CD163 | IHC | ✓ | _ | ✓ | 7 |
| Petrillo, et al. [23] | 2015 | 2009.3–2011.12 | 55 (22–79) | 84 | SCC, AC | CD68, CD163 | IHC | _ | ✓ | _ | 6 |
| Ding, et al. [24] | 2014 | 2015.1–2017.12 | NR | 55 | SCC | CD68 | IHC | ✓ | _ | ✓ | 7 |
| Liu, et al. [25] | 2005 | 1996.1–1998.12 | 39 (25–68) | 59 | SCC, AC | CD68 | IHC | ✓ | _ | ✓ | 6 |
Abbreviations: AC, cervical adenocarcinoma; ASC, adenosquamous carcinoma of cervix; FCM, flow cytometry; IHC, immunohistochemistry; NC, neuroendocrine carcinoma; NR, not reported; SCC, cervical squamous cell carcinoma.